Alignment Healthcare (ALHC) Q1 2023: Membership Surges 16.5% as Risk Model Shift Drives Competitive Tailwind

May 4, 2023 | By EarningsIQ Research

Alignment Healthcare delivered robust membership growth and margin discipline, positioning itself to capitalize on CMS risk model changes and evolving Medicare Advantage dynamics. The company’s clinical model and operational investments are translating to tangible advantages, especially as regulatory shifts begin to differentiate winners and losers. With a neutral-to-positive revenue outlook for 2024 under the new risk adjustment framework, Alignment is leaning into scale and retention to sustain momentum.

Summary

• Regulatory Tailwind Emerges: CMS risk model and star rating changes are expected to favor Alignment’s operating model.
• Operational Leverage in Focus: SG&A discipline and scalable clinical programs underpin improving cost structure.
• 2024 Growth Strategy: Leadership signals deepening market share and retention as the next phase of expansion.

Business Overview

Alignment Healthcare is a Medicare Advantage (MA) plan operator, generating revenue primarily from monthly premiums paid by CMS for each enrolled senior. The business is structured around its health plan membership, with a focus on clinical innovation through programs like Care Anywhere, a high-touch care management platform for complex members, and AVA, its proprietary analytics engine. Revenue is driven by member growth, risk adjustment scores (RAF), and clinical quality outcomes (star ratings), with California as its core market and expansion underway in states like Florida and Texas.

Performance Analysis

Alignment’s Q1 2023 results reflect a business scaling efficiently, with health plan membership up 16.5% year over year and revenue growth of 27%. The company’s ability to maintain an 89.7% medical benefit ratio (MBR, claims cost as a percentage of premium revenue) signals continued success in managing utilization, anchored by its Care Anywhere and AVA platforms. Adjusted gross profit improved, and negative EBITDA narrowed, reflecting both operational discipline and the timing of SG&A expenses.

SG&A leverage is a clear theme, with costs as a percentage of revenue down 270 basis points year over year (excluding equity comp), even as investments in new markets and talent ramp. The company benefited from some expense timing in Q1, but expects those costs to normalize over the coming quarters as hiring and marketing catch up with membership growth. Utilization trends remain stable, with inpatient admissions per thousand consistent with historical performance, and outpatient activity normalizing to pre-COVID patterns.

• Membership Growth Outpaces Market: 85% of new members are plan switchers, not traditional Medicare conversions, underscoring competitive differentiation.
• Risk Score Management Disciplined: RAF of 1.13, including 30% dual-eligible members, positions Alignment well for risk model changes.
• Operational Scale Initiatives Gaining Traction: Early investments in vendor management, CRM, and call center insourcing are supporting retention and efficiency.

Cash and investments remain substantial, providing flexibility for continued investment in growth and scale as the company navigates evolving regulatory and market conditions.

Executive Commentary

Strategic Positioning

1. Regulatory Change as Competitive Advantage

Alignment is positioned to benefit from CMS’s risk model (V28) and star rating methodology changes, as its business has long prioritized clinical outcomes and prudent risk adjustment. The phased-in risk model is expected to be neutral to slightly positive for 2024 revenue, while competitors—particularly in California—face greater headwinds due to past aggressive risk adjustment tactics.

2. Scale and Retention Initiatives

Leadership is doubling down on deepening market share in existing states, leveraging brokers, expanding captive agent capacity, and investing in retention. Enhanced CRM systems, stricter vendor oversight, and insourced call center operations are being deployed to target five-star retention rates, supporting both top-line and margin expansion.

3. Clinical Model and Technology Differentiation

Care Anywhere, a high-touch care management program, and AVA, an analytics platform, remain central to Alignment’s ability to control utilization and deliver consistent MBR performance. These platforms leverage data and machine learning to identify at-risk members, drive engagement, and support scalable clinical operations—critical as the company expands beyond California.

4. Disciplined Cost Structure and Capital Allocation

Operational leverage is being realized through disciplined SG&A management, with investments in claims automation and productivity yielding faster visibility into trends and supporting future margin improvement. A strong cash position supports ongoing investment in growth markets and potential M&A, though management stresses caution to preserve operational quality.

5. Prudent Growth in Expansion Markets

While Florida and Texas are expansion priorities, management emphasizes that core growth targets can be met without over-reliance on these new states. The playbook centers on replicating the California model—network depth, distribution quality, and product design—while solving for local distribution challenges to unlock incremental upside.

Key Considerations

This quarter marks a transition for Alignment as regulatory clarity and operational investments converge, setting the stage for a differentiated growth and margin story in 2024 and beyond.

Key Considerations:

• Regulatory Tailwind in California: New CMS rules are expected to disadvantage competitors with higher RAFs and less clinical rigor, amplifying Alignment’s relative strengths.
• Retention and Member Experience Focus: Steps to improve vendor oversight and customer service are aimed at driving five-star retention and star rating sustainability.
• SG&A Timing and Seasonality: Investors should expect some normalization of SG&A in coming quarters as hiring and marketing investments catch up with growth.
• Utilization Stability Remains a Core Strength: Consistent inpatient and outpatient trends support margin visibility and confidence in guidance.
• Potential for M&A: Management is open to scale-driven acquisitions but prioritizes operational excellence and cultural fit over rapid expansion.

Risks

Key risks include potential volatility in medical utilization, especially if hospital demand accelerates beyond expectations, and the execution risk in scaling retention and operational initiatives. Regulatory changes, while currently favorable, could introduce unforeseen challenges if CMS policy shifts again. Competitive responses in core and new markets may pressure growth or margin if incumbents aggressively adjust benefits or pricing.

Forward Outlook

For Q2 2023, Alignment guided to:

• Health plan membership between 111,200 and 111,400
• Revenue of $433 million to $438 million
• Adjusted gross profit of $47 million to $50 million
• Adjusted EBITDA loss of $13 million to $10 million

For full-year 2023, management raised revenue guidance and reiterated other targets:

• Health plan membership between 113,000 and 115,000
• Revenue of $1.71 billion to $1.735 billion
• Adjusted gross profit of $205 million to $217 million
• Adjusted EBITDA loss of $34 million to $20 million

Management highlighted that utilization trends remain stable, SG&A will normalize with growth, and operational initiatives are expected to offset most or all of the V28 risk model impact for 2024.

• Benefit design and bid process for 2024 are underway, with more detail to be shared next quarter.
• Retention, scale, and clinical innovation will remain strategic priorities to drive both growth and margin improvement.

Takeaways

Alignment Healthcare is emerging as a regulatory beneficiary, leveraging its disciplined clinical model and operational investments to outpace the market. The company’s ability to navigate risk model changes, drive membership growth, and sustain margin discipline positions it as a differentiated player in Medicare Advantage.

• Regulatory Shifts Create Relative Advantage: Alignment’s historical focus on clinical outcomes and prudent risk adjustment is now a competitive asset as CMS tightens standards.
• Operational Scale and Retention Drive Margin Visibility: Early evidence of SG&A leverage and retention initiatives support confidence in the path to profitability.
• Watch for Execution in Expansion Markets and Benefit Design: The next phase of growth will hinge on replicating the California model elsewhere and navigating the evolving bid environment for 2024.

Conclusion

Alignment Healthcare’s Q1 results validate its strategic approach, with robust membership growth, cost discipline, and clear regulatory tailwinds. The company’s focus on clinical quality, operational scale, and member retention sets a foundation for continued outperformance as the Medicare Advantage landscape evolves.

Industry Read-Through

Alignment’s quarter underscores a pivotal shift in Medicare Advantage, as CMS’s recalibration of risk adjustment and star ratings begins to separate operators with genuine clinical rigor from those reliant on aggressive coding or marketing. Plans with disciplined RAF management and scalable care models are best positioned to weather upcoming margin pressures, while those with legacy risk adjustment strategies face headwinds. Retention, member experience, and operational leverage are rising in strategic importance, signaling that the era of easy growth through benefit expansion and aggressive marketing is ending. Competitors should prepare for a more level regulatory playing field and intensifying focus on clinical outcomes and cost control.

ALHC Healthcare Medicare Advantage Regulation Risk Adjustment Membership Growth Clinical Innovation Retention